What Researchers Did
Researchers conducted a systematic review and meta-analysis of 13 studies involving 780 patients to evaluate the efficacy of hyperbaric oxygen combination therapy for ulcerative colitis.
What They Found
They found that hyperbaric oxygen combination therapy was superior to conventional therapy in achieving clinical remission. Patients receiving hyperbaric oxygen combination therapy had a 1.62 times higher likelihood of achieving clinical remission (95% CI 1.42 to 1.84).
What This Means for Canadian Patients
Canadian patients with ulcerative colitis may benefit from hyperbaric oxygen combination therapy as a complementary treatment option. This therapy could potentially improve their chances of achieving clinical remission when used alongside conventional treatments.
Canadian Relevance
This study has no direct Canadian connection as none of the included studies or authors are identified as Canadian.
Study Limitations
The abstract does not detail specific study limitations, but potential issues like heterogeneity among the included studies are common in meta-analyses.